Recap: Coherus BioSciences Q4 Earnings

Coherus BioSciences CHRS reported its Q4 earnings results on Wednesday, March 13, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.

Coherus BioSciences missed estimated earnings by -417.0%, reporting an EPS of $-0.62 versus an estimate of $-0.12.

Revenue was up $46.17 million from the same period last year.

Last quarter the company beat on EPS by $0.04 which was followed by a 30.0% drop in the share price the next day.

Here's a look at Coherus BioSciences's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.31	-0.52	-0.57	-0.84
EPS Actual	-0.27	-0.38	-0.75	-0.60
Revenue Estimate	83.56M	50.83M	47.44M	51.22M
Revenue Actual	74.57M	58.72M	32.44M	45.35M

To track all earnings releases for Coherus BioSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar